NCT06539273Phase 3Completed
Exosome Treatment in Androgenetic Alopecia
Effectiveness of Exosome Treatment in Androgenetic Alopecia - Outcomes of a Prospective Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Phase 3
- Sponsor
- Yeditepe University Hospital
- Participants (registry)
- 30
- Start
- January 2024
- Primary completion
- April 2024
- Study completion
- May 2024
- Last registry update
- July 2025
- Countries
- Turkey
Conditions studied: Androgenetic Alopecia, Exosomes
Interventions: Exosome Complex, RNA
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.